ABSTRACT Antisera raised against synthetic dynorphin or [Leu5]enkephalin demonstrate immunostaining in hippocampal mossy fibers and in dentate granule cells. However, dynorphin immunoreactivity (ir) appears to be denser in immunocytochemical preparations and is quantitatively -greater by radioimmunoassay than enkephalin-ir. Immunostaining with dynorphin antisera is eliminated by adsorption with 1-100 pM dynorphin-17 whereas immunostaining with enkephalin antisera is eliminated by adsorption with 1-100 ,uM [Leu5Jenkephalin,, or a-neo-endorphin. Intrahippocampal colchicine injections, which selectively destroy dentate granule cells, significantly decrease the dynorphin-ir and enkephalin-ir levels in rat-hippocampus. Intraventricularly administered kainic acid, which selectively destroys CA3-4 pyramidal cells, results in an increase of enkephalin immunostaining in mossy fibers and a significant increase in enkephalin-ir by radioimmunoassay in whole hippocampus. The enkephalin-ir cells and fibers in entorhinal/ perirhinal cortex, which innervate rat hippocampus and dentate gyrus, do not contain dynorphin-ir.
Iontophoretically applied opioid peptides elicit potent excitatory responses from hippocampal CAl pyramidal cells (1, 2) . However, initial immunocytochemical (ICC) studies of endogenous opioid peptides revealed only a sparse distribution of enkephalin-immunoreactive (ir) cells and fibers in the hippocampus (3, 4) . More recent examinations have revealed that the highest concentration of enkephalin-ir is located in the dentate gyrus and in the CA34 fields of rat hippocampus (5, 6) .
Enkephalin-ir is present in two major hippocampal systems (7) (8) (9) : the intrinsic dentate granule cell-mossy fiber path which innervates CA3-4 pyramidal cells (10) and the extrinsic lateral perforant/tempero-ammonic path which arises in entorhinal cortex and innervates both granule and pyramidal cells (11) . However, mossy fibers exhibit weak enkephalin-ir, suggesting that crossreacting opioid peptides may be at least partially responsible for the enkephalin immunostaining in this pathway (9, 12) . Likely candidates are the COOH-terminal-extended [Leu5]enkephalin peptides dynorphin and a-neo-endorphin which have been detected in the hippocampus (13) (14) (15) .
We report here the results of radioimmunoassay (RIA) and ICC experiments to distinguish the dynorphin-ir and enkephalin-ir in the rat hippocampus. Intrahippocampal colchicine injections were used to produce selective degeneration of dentate granule cells and mossy fibers (16) , and intracerebroventricular infusions of kainic acid were used to increase mossy fiber activity (17) , resulting in destruction of CA3-4 pyramidal cells (18) . These selective neurotoxic actions altered the apparent opioid peptide content ofthe hippocampus accordingly. Our data are compatible with the view that the two major enkephalin-ir hippocampal pathways contain different opioid peptide families.
MATERIALS AND METHODS
Thirty Sprague-Dawley (Charles River Breeding Laboratories) rats (200-350 g) were used. All surgical manipulations and perfusions were performed under chloral hydrate anesthesia (350 mg/kg, intraperitoneally). For intracerebroventricular infusions of kainic acid or phosphate-buffered saline (Pi/NaCl) infusions, cannulae were implanted in the left lateral ventricle of 16 rats. Seven days after implantation, the rats were anesthetized with chloral hydrate. Kainic acid (1 ,g in 1 ,ul of P1/NaCl) or 1 ,ul of Pi/NaCl alone was infused over 1 min through a microliter syringe connected to an inner cannula by a short length of polyethylene tubing. Colchicine (3 ,g in 0.6 ,ul of Pi/NaCl) was injected into the dorsal and ventral hilus of the left hippocampus, and P1/NaCl alone was injected into identical sites in the right hippocampus of eight rats as described (16) . In order to visualize immunostained cell bodies by blocking axoplasmic transport (20) , four additional rats were given colchicine (1 ,g in 1 ,ul ofsaline) by intracerebroventricular injection 24- (23) in a blind fashion.
ICC Processing. Perfused brains were dissected and postfixed for 2-3 hr. Samples were then transferred to 16% sucrose and stored at 40C overnight. Adjacent, frozen, coronal sections (50 htm) were cut on a freezing microtome, every 250 1Lm through the rostro-caudal extent of the hippocampus. Adjacent free-floating sections were collected in 10 mM Pi/NaCl and then incubated with anti-[Leu5]enkephalin or anti-dynorphin-17 at dilutions of 1:1,000 to 1:2,000 at 40C for 18 hr. The sections were rinsed with two or three changes of Pi/NaCl and then incubated in goat anti-rabbit IgG horseradish peroxidase for 2 hr or in biotinylated goat anti-rabbit IgG (Vectastain, Vec- tor, Burlingame, CA) for 1 hr. After two Pi/NaCl rinses, the sections incubated with biotinylated IgG were placed in a solution of avidin-biotin-horseradish, peroxidase complex (Vectastain) for 1 hr and then rinsed twice in Pi/NaCl. All sections were incubated in 0.05% 3',3'-diaminobenzidine tetrahydrochloride (Electron Microscopy Sciences, Fort Washington, PA) in 0.05 M phosphate buffer with 0.003% H202. The sections were mounted on gelatin-coated slides and coverslipped in paraffin oil or counterstained, dehydrated, and coverslipped in Permount.
Statistical Analysis. RIA data were analyzed by a two-way analysis ofvariance followed by individual comparisons by t test for independent means. RESULTS Dynorphin immunostaining was blocked when dynorphin antiserum was preadsorbed with 1-100 ,uM dynorphin-17 but was not affected by adsorption with 1-100 1LM dynorphin-(1-13), a-neo-endorphin, or [Leu5]enkephalin (Table 1) . Enkephalin immunostaining was abolished when enkephalin antiserum was preadsorbed with 1-100 ,M.
[Leu5]enkephalin, dynorphin-17, dynorphin-(1-13), or a-neo-endorphin.
Unilateral intrahippocampal colchicine injections (16) , aimed at the left dorsal and ventral dentate gyrus, selectively destroyed the ipsilateral dentate granule cells without affecting other cell.types ofthe hippocampus. Seven days after colchicine (10) . The dentate granule cells and the CAl pyramidal cells remained intact.
In untreated adult rats, enkephalin-ir was observed in the mossy fibers and in the entorhinal cortical projection to the hippocampus but dynorphin-ir was detected only in the mossy fiber system. Enkephalin-ir observed in the mossy fibers appeared less intense than dynorphin-ir (compare Fig. 1 Although mossy fibers arise from dentate granule cells, few granule cells ( Fig. 2A) showed either enkephalin-ir or dynorphin-ir unless the animal had been treated with colchicine (intracerebroventricular injection). Injection of 50 Ag ofcolchicine blocked axoplasmic transport but was not cytotoxic. The types and distribution of dentate cells which then demonstrated dynorphin-ir were similar to previous findings for enkephalin-ir cells (7) . Dentate granule cells were seen at different locations within the granule cell layer (Fig. 2 A-C) . Not all dynorphinir cells in the dentate gyrus were granule cells; scattered, isolated, multipolar cells in the dentate molecular layer also exhibited dynorphin immunostaining (Fig. 2D) does not crossreact with [Leu5]enkephalin or a-neo-endorphin; (ii) dynorphin-ir is found in greater concentration in the hippocampal formation than is enkephalin-ir; (iii) enkephalin-ir increases in the-hippocampal formation, after kainic acid treatment; (iv) dynorphin-ir and enkephalin-ir significantly decrease after colchicine-induced dentate granule cell destruction; (v) the lateral perforant/tempero-ammonic pathway which contains enkephalin-ir does not contain dynorphin-ir. These relationships are summarized in Fig. 3 .
The distribution of dynorphin-ir intrinsic to the hippocampal formation is similar to that which has been described for enkephalin-ir with antiserum A206 (7) . The crossreactivity of this antiserum with dynorphin and a-neo-endorphin in ICC preparations suggests that the majority, if not all, of the enkephalin- . : -. . [Leu5]Enkephalin may be cleaved from dynorphin or a-neoendorphin or from an additional COOH-terminal-extended [Leu5]enkephalin present in the dynorphin/a-neo-endorphin prohormone (24, 25) . [Met5]Enkephalin-containing peptides may be cleaved from a precursor similar or identical to the adrenal pro-enkephalin (26, 27) . Antisera raised against fragments of pro-enkephalin such as BAM22 (28) (Table 2 ). This effect may represent a transient neurotoxic effect of kainic acid on ipsilateral mossy fibers presynaptic to degenerating pyramidal cells (29) . The mechanism by which kainic acid causes a bilateral increase in hippocampal opioid peptide content most likely is related to the development ofgranule cell epileptiform activity which spreads from the ipsilateral hippocampus to the contralateral hippocampus and limbic cortex (30) . The excitatory discharge of mossy fibers presumably causes an acute depletion ofopioid peptides (19) followed by a postdischarge depression ofrelease, resulting in a sustained increase in opioid peptide content. The greater increase in hippocampal enkephalin-ir than in dynorphin-ir may reflect the spread of excitatory discharge to the entorhinal cortex or an increased cleavage of [Met5]-and [Leu5]enkephalin peptides from their precursors, or both, under these conditions. Our results indicate that dynorphin (and possibly other peptides containing the [Leu5]enkephalin sequence), rather than enkephalin itself, predominates in the hippocampal mossy fiber system. However, the dense immunostaining of mossy fibers with dynorphin antiserum 84C, which is directed to the COOH terminus, raises the possibility that 84C may be reading a COOH-terminal fragment of dynorphin-17. Dynorphin fragments 1-8 and 9-17 have been found in regional concentrations which are equimolar with a-neo-endorphin and up to 10 times greater than dynorphin-17 (31, 32) .
In light ofour results, investigations ofthe role ofopioid peptides in the hippocampal formation must now be expanded. Detection and comparison of the electrophysiological actions ofCOGH-terminal-extended [Leu5]enkephalin peptides at the mossy fiber-pyramidal cell synapse (33) and of [Met5]enkephalin peptides at the lateral perforant path-dentate granule cell synapse are necessary. Furthermore, the endogenous opioid peptides and possible co-transmitters (12) released at these synapses must be identified and the receptor subtype(s) that mediates the actions of these opioid peptides in the hippocampus must be characterized.
